ATE245626T1 - Synthetische mehrfach ungesättigte fettsäure- derivate - Google Patents

Synthetische mehrfach ungesättigte fettsäure- derivate

Info

Publication number
ATE245626T1
ATE245626T1 AT95935757T AT95935757T ATE245626T1 AT E245626 T1 ATE245626 T1 AT E245626T1 AT 95935757 T AT95935757 T AT 95935757T AT 95935757 T AT95935757 T AT 95935757T AT E245626 T1 ATE245626 T1 AT E245626T1
Authority
AT
Austria
Prior art keywords
acid
pct
polyunsaturated fatty
glycine
fatty acid
Prior art date
Application number
AT95935757T
Other languages
English (en)
Inventor
Merilyn Joy Sleigh
Fred Widmer
Paul Adam Schober
Antonio Ferrante
Alfred Poulos
Deborah Ann Rathjen
Original Assignee
Peptech Ltd
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Ltd, Womens & Childrens Hospital filed Critical Peptech Ltd
Application granted granted Critical
Publication of ATE245626T1 publication Critical patent/ATE245626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
AT95935757T 1994-10-26 1995-10-25 Synthetische mehrfach ungesättigte fettsäure- derivate ATE245626T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM9065A AUPM906594A0 (en) 1994-10-26 1994-10-26 Synthetic polyunsaturated fatty acid analogues
PCT/AU1995/000717 WO1996013507A1 (en) 1994-10-26 1995-10-25 Synthetic polyunsaturated fatty acid analogues

Publications (1)

Publication Number Publication Date
ATE245626T1 true ATE245626T1 (de) 2003-08-15

Family

ID=3783583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95935757T ATE245626T1 (de) 1994-10-26 1995-10-25 Synthetische mehrfach ungesättigte fettsäure- derivate

Country Status (12)

Country Link
US (1) US5998476A (de)
EP (1) EP0804411B1 (de)
JP (1) JPH10508011A (de)
KR (1) KR100382159B1 (de)
CN (1) CN1109016C (de)
AT (1) ATE245626T1 (de)
AU (1) AUPM906594A0 (de)
DE (1) DE69531359T2 (de)
DK (1) DK0804411T3 (de)
ES (1) ES2203646T3 (de)
PT (1) PT804411E (de)
WO (1) WO1996013507A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2328155B (en) * 1996-04-12 2000-08-02 Peptide Technology Pty Limited Methods of treating immunopathologies using polyunsaturated fattyacids
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
AU784116B2 (en) * 1999-09-17 2006-02-09 Peplin Biolipids Pty Ltd Anti-cancer nitro- and thia-fatty acids
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
WO2003007876A2 (en) * 2001-06-25 2003-01-30 University Of Massachusetts N-fatty acid-amino acid conjugates and therapeutic uses
KR100477681B1 (ko) * 2002-11-20 2005-03-21 삼성전자주식회사 화상형성장치
CA2436650A1 (en) 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
DE10351111A1 (de) * 2003-11-03 2005-06-16 Langlotz, Rainer Arzneimittel und Verfahren zu ihrer Herstellung
CA2554735A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
US7544714B2 (en) * 2004-07-16 2009-06-09 University Of Massachusetts Lipid-amino acid conjugates and methods of use
US20100104546A1 (en) * 2007-02-05 2010-04-29 Children, Youth And Women's Health Service Modulators of antigen-dependent t cell proliferation
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
EP2598128B1 (de) 2010-07-28 2018-03-28 Life Technologies Corporation Azidhaltige antivirale verbindungen
WO2016130417A1 (en) * 2015-02-11 2016-08-18 Omthera Pharmaceuticals Inc Omega-3 fatty acid prodrug compounds and uses thereof
KR101963559B1 (ko) 2015-07-08 2019-03-28 한국화학연구원 피롤리딘 카복스아미도 유도체 및 이의 제조 방법 및 용도
US11690825B2 (en) 2016-03-09 2023-07-04 Board Of Regents, The University Of Texas System 20-HETE receptor (GPR75) antagonists and methods of use
KR102058853B1 (ko) 2018-02-28 2019-12-24 브릿지바이오테라퓨틱스(주) 지질화 펩타이드의 수용성 염과 이의 제조 방법 및 용도
US20230065371A1 (en) * 2020-01-30 2023-03-02 Silicycle Inc. Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939174A (en) * 1988-02-26 1990-07-03 Shashoua Victor E Appetite suppression with dopamine-fatty acid conjugates
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
EP0367724B1 (de) * 1988-10-31 1993-02-10 Sandoz Nutrition Ltd. Organische Verbindungen
HU207287B (en) * 1989-01-17 1993-03-29 Biosignal Kutato Fejlesztoe Kf Polyene fatty acid derivatives of tyrozine-quinaze inhibiting activity and pharmaceutical composition containing them as active component
JPH02225411A (ja) * 1989-02-28 1990-09-07 Nippon Oil & Fats Co Ltd 高度不飽和脂肪酸の溶血性低下方法
JPH03236315A (ja) * 1989-12-05 1991-10-22 Nippon Oil & Fats Co Ltd 抗精神病薬
DE69231592T2 (de) * 1991-06-24 2001-06-21 Women's And Children's Hospital, North Adelaide Verfahren und zusammensetzungen zur behandlung von malaria und anderen erkrankungen
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
EP0689835A3 (de) * 1994-06-30 1996-04-17 Ajinomoto Kk Zusammensetzung enthaltend ein Aminosäurengemisch und mindestens ein N-3 Fettsäure

Also Published As

Publication number Publication date
ES2203646T3 (es) 2004-04-16
PT804411E (pt) 2003-12-31
WO1996013507A1 (en) 1996-05-09
DE69531359T2 (de) 2004-04-22
US5998476A (en) 1999-12-07
EP0804411A1 (de) 1997-11-05
EP0804411B1 (de) 2003-07-23
DK0804411T3 (da) 2003-11-24
KR100382159B1 (ko) 2004-11-16
JPH10508011A (ja) 1998-08-04
DE69531359D1 (de) 2003-08-28
AUPM906594A0 (en) 1994-11-17
CN1167481A (zh) 1997-12-10
CN1109016C (zh) 2003-05-21
KR970707074A (ko) 1997-12-01
EP0804411A4 (de) 1999-06-16

Similar Documents

Publication Publication Date Title
ATE245626T1 (de) Synthetische mehrfach ungesättigte fettsäure- derivate
ATE239717T1 (de) Ester und amide von nicht-steroidalen entzündungs-hemmenden carbonsäuren die als anti-oxidantien 5- lipoxygenase-hemmer und nicht-steroidale entzündungs-hemmende mittel verwendet werden können
ATE331510T1 (de) Verwendung von polyungesättigten fettsäuren zur primären vorbeugung von kardiovaskulären anfällen
BR9713479A (pt) Preparação farmacêutica compreendendo ácido eicosapentaenóico e/ou ácido estearidÈnico.
HUP0004230A2 (hu) Probucol monoésztereinek alkalmazása VCAM-1 gátlására alkalmas gyógyászati készítmények előállítására
ATE218336T1 (de) Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
CY1106085T1 (el) Το ανθρωπινο γονιδιο της δελτα-5δεσατουρασης και οι χρησεις του
BR9508298A (pt) Inibidores de indolizina de spla2
DE69524639D1 (de) Modifizierte mehrfach ungesättigte fettsäuren
ES8606235A1 (es) Procedimiento para preparar nuevos derivados hidroximetilce-tonicos de acidos grasos insaturados
YU89891A (sh) SMEŠE TGF-beta
DE69612755D1 (de) Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
DE69832520D1 (de) Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
DE69938306D1 (de) Pflanzen, samen und öle mit erhöhtem gesamtgehalt an einfachgesättigten fettsäuren
DK0977560T3 (da) Ibuprofen-thioestere som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer (CoA-thioestere af arylpropionsyrer, aryleddikesyrer og salicylater som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer)
DE3767763D1 (de) Eisen enthaltende zusammensetzung und verfahren zur behandlung von krebs.
BR9800982A (pt) Processo para aperfeiçoamento de ganho de peso e eficiência de conversão de alimentos de suìnos.
ATE164518T1 (de) Verwendung von fettsäuren zur behandlung von abnormalen verkalkung des gewebes
DE69324862D1 (de) Arzneimittel, die Ester omega-3 polyungesättigter Säuren enthalten und deren Verwendung in der topischen Behandlung morbider Erkrankungen
ATE444745T1 (de) Verwendung von epa and dha zur sekundären prevention von schlaganfällen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0804411

Country of ref document: EP

REN Ceased due to non-payment of the annual fee